Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Nanocarriers improve skin disease treatment by targeting hair follicles effectively.

Smart microneedles can deliver drugs painlessly and accurately for diseases like diabetes and tumors.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Silver nanoparticles are useful in medicine and technology for their antibacterial properties and potential in drug delivery and dentistry.

Nanoemulgel is a promising method for applying topical drugs effectively, but safety must be evaluated due to new administration techniques.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Microneedles offer a painless way to deliver drugs effectively but need more research before they can be widely used.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

TNF-alpha inhibitors can cause various immune-related skin issues.